Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods

Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods

US Patent 8968766 · Granted Mar 3, 2015

Estimated economic value: $57,210,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multi-kinase inhibitors of VEGF and TGF beta and uses thereof2025
Bioerodible cross-linked hydrogel implants and related methods of use2024
Multikinase inhibitors of VEGF and TGF beta and uses thereof2024
Rho kinase inhibitor releasing implants and related methods of use2024
Bioerodible polyester polymer axitinib ocular implants and related methods of us2024
Multikinase inhibitors and uses in reproductive and digestive tract fibrosis2022
Bioerodible cross-linked hydrogel implants and related methods of use2022
Multikinase inhibitors and uses in prostatic hyperplasia and urinary track disea2022
Multikinase inhibitors and uses in ocular fibrosis2022
High viscosity macromolecular compositions for treating ocular conditions2021
High viscosity macromolecular compositions for treating ocular conditions2021
Microneedle array with active ingredient2021